Title
Addressing social determinants to end tuberculosis
Date Issued
24 March 2018
Access level
open access
Resource Type
editorial
Author(s)
Wingfield T.
TOVAR HUAMANI, MARCO ANTONIO
Saunders M.J.
DATTA, SUMONA
EVANS, ANNABLE CARLTON
Asociación Benéfica PRISMA
Asociación Benéfica PRISMA
Asociación Benéfica PRISMA
Publisher(s)
Lancet Publishing Group
Start page
1129
End page
1132
Volume
391
Issue
10126
Language
English
OCDE Knowledge area
Políticas de salud, Servicios de salud Epidemiología
DOI
10.1016/S0140-6736(18)30484-7
Scopus EID
2-s2.0-85044110272
PubMed ID
29595481
Source
The Lancet
ISSN of the container
0140-6736
Sponsor(s)
CAE and MAT were involved in the ISIAT study and we are all involved in the HRESIPT and CRESIPT studies discussed here. TW was a winner of The Academy of Medical Sciences– Lancet Young Investigator Prize in 2017. We declare no other competing interests. We, the IFHAD group, receive funding from the Wellcome Trust, Department for International Development Civil Society Challenge Fund, Joint Global Health Trials consortium, Bill & Melinda Gates Foundation, Imperial College National Institutes of Health Research Biomedical Research Centre, Foundation for Innovative New Diagnostics, Sir Halley Stewart Trust, WHO, TB REACH, National Institute for Health Research (UK), Academy of Medical Sciences, and IFHAD.
Sources of information: Directorio de Producción Científica Scopus